PATENT CLAIM ANALYSIS

Application Number: 16243251
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["549", "419000"]

Abstract:
The invention relates to N-hydroxysulfonamide derivatives that donate nitroxyl (HNO) under physiological conditions and are useful in treating and/or preventing the onset and/or development of diseases or conditions that are responsive to nitroxyl therapy, including heart failure and ischemia/reperfusion injury. Novel N-hydroxysulfonamide derivatives release HNO at a controlled rate under physiological conditions, and the rate of HNO release is modulated by varying the nature and location of functional groups on the N-hydroxysulfonamide derivatives.

Claim (Index 2):
The method of  claim 1 , wherein R 3 , R 4 , R 5 , R 6 , and R 7  are independently selected from the group consisting of H, Cl, F, I, Br, SO 2 CH 3 , SO 2 NHOH, CF 3 , NO 2 , phenyl, CN, OCH 3 , OCF3, t-Bu, O-iPr, 4-nitrophenyloxy, propane-2-thiyl, propane-2-sulfinyl, morpholino, N-methyl-peperazino, dimethylamino, peiperidino, cyclohexyloxy, cyclopentylsulfanyl, phenylsulfanyl and phenyl sulfinyl.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 99.0
- Lexical Diversity: 1.51923
- Patent Class: 549.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15286145', '13531364', '12239705', '14857308', '14815917']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7939417986765052
- 35 USC 102 Novelty (BERT): 0.518899302468787
- Combined Prediction Score: 0.7664375490557334
- Mean Citation Score: 317.738606
- Max Citation Score: 324.2645
- Similarity Product: 249.64094466370344

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test